The Construction & Economy Research Institute of Korea made the remarks in a report titled "Evaluation of and Areas for ...

The phase 1b/2 ELEVATE study evaluated everolimus, an mTORC1 inhibitor, plus elacestrant, a next-generation, oral selective ER degrader, in adult patients with ER+/HER2- breast cancer.

Over the past seven months, American Rare Earths Limited ('ARR' or the 'Company') has continued to advance Halleck Creek from a resource-stage ...

Tungsten Mining (ASX: TGN) has unveiled a strong pre-feasibility study for its 100%-owned Mt Mulgine Tungsten Project in ...

Bullfrog Gold Corporation ("Bullfrog Gold") (TSXV: FROG) (OTCQX: BFROF) is pleased to announce that its common shares have ...

Nickel spot prices were slightly lower the last month. Nickel market news - LME nickel prices fall on expectations of higher ...

ArriVent BioPharma is also advancing ARR-002, a novel dual-target therapy for patients with ovarian and endometrial cancers.

Kevin Warsh's Jackson Hole remarks hit gold, but investment banks remain bullish and Aussie explorers are drilling with real ...

An assessment of the Hornets roster changes, and place in the NBA, in the post LaMelo Ball and Miles Bridges era.

Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEA. ZIIHERA plus chemotherapy demonstrated statistically ...